Prime Minister Justin Trudeau announced Tuesday that the Canadian government would invest $199.16 million to help Ontario’s Resilience Biotechnologies Inc. increase its manufacturing of a number of vaccines and therapeutics, including those using mRNA technology.
Canada
Canada invests nearly $200M to help Ontario facility produce mRNA vaccines
More Videos
-
Missed credit payments higher among younger Canadians: report
-
Business Matters: BMO, Scotiabank reserving money for bad loans
-
Park’N Fly data breach hits roughly 1M customers
-
Calls for federal government to improve Indigenous procurement program
-
CN, CPKC rail service resumes after 4-day shutdown
-
Trains running but Teamsters vow to challenge back-to-work ruling
You are viewing an Accelerated Mobile Webpage.
View Original Article